Araclon Biotech Overview

  • Founded
  • 2004
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $10.9M
Latest Deal Amount

Araclon Biotech General Information

Description

Provider of biotechnology related services. Developer of therapies and diagnostic methods for Alzheimer's disease. The company focuses on research and development of therapies and diagnostic methods to be applied to degenerative diseases.

Contact Information

Website
www.araclon.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Grifols
Primary Office
  • Vía Hispanidad
  • 21 50009 Zaragoza
  • Spain
+34 976 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Araclon Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 29-Feb-2012 $10.9M 000.00 Completed Generating Revenue
2. IBO 15-Feb-2012 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view Araclon Biotech’s complete valuation and funding history, request access »

Araclon Biotech Patents

  • 108

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 7

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Araclon Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-6689993-B2 Amyloid conjugates and uses and methods thereof Active 15-Feb-2016 0000000000
AU-2017221070-B2 Amyloid conjugate and uses and methods thereof Active 15-Feb-2016 00000000000 0
EP-3390426-A1 Amyloid conjugate and uses and methods thereof Granted 15-Feb-2016 00000000000
ES-2571055-A1 Amyloid conjugate and uses and procedures thereof (machine-translation by google translate, not legally binding) Granted 15-Feb-2016 00000000000 0
ES-2747899-T3 Amyloid conjugate and uses and procedures thereof Active 15-Feb-2016 A61K47/643
To view Araclon Biotech’s complete patent history, request access »

Araclon Biotech Executive Team (1)

Name Title Board Seat Contact Info
Manuel Sarasa Founder, Chief Executive Officer & Chief Scientific Officer
To view Araclon Biotech’s complete executive team members history, request access »

Araclon Biotech Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Going Investment Venture Capital Minority 000 0000 000000 0
Mobius Venture Capital Venture Capital Minority 000 0000 000000 0
VIA Technologies Corporation Minority 000 0000 000000 0
To view Araclon Biotech’s complete investors history, request access »

Ready to get started?

Request a free trial